Konecranes (PK)【KNCRY】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Konecranes Plc (PK) (KNCRY) 銘柄情報

Konecranes Plc (PK) (KNCRY)

13.53

0.00

( 0.00% )

更新日時： 23:40:08

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

13.53

買値

11.75

売値

13.75

出来高

-

0.00 日の範囲 0.00

7.74 52 週間の範囲 14.11

時価総額

前日終値

13.53

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

395

発行済株式数

396,011,250

配当利回り

2.14%

PER

94.12

1 株当たり利益 (EPS)

0.7

歳入

3.98B

純利益

275.6M

セクター

Cranes,hoists,monorail Sys

業界

Machinery Heavy Div'd

ウェブサイト

www.konecranes.com

本社

Hyvinkaa, Fin

設立

2002

Konecranes Plc (PK) is listed in the Cranes,hoists,monorail Sys sector of the その他OTC with ticker KNCRY. The last closing price for Konecranes (PK) was US$13.53. Over the last year, Konecranes (PK) shares have traded in a share price range of US$ 7.74 to US$ 14.11.

Konecranes (PK) currently has 396,011,250 shares in issue. The market capitalisation of Konecranes (PK) is US$5.36 billion. Konecranes (PK) has a price to earnings ratio (PE ratio) of 94.12.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.32	2.42240726722	13.21	13.53	13.21	527	13.33278129	DR
4	-0.47	-3.35714285714	14	14.1	13.21	542	13.70370849	DR
12	-0.58	-4.11055988661	14.11	14.11	13.21	395	13.72182094	DR
26	2.87	26.9230769231	10.66	14.11	10.66	374	12.77153209	DR
52	5.79	74.8062015504	7.74	14.11	7.74	1994	10.9365394	DR
156	5.56	69.7616060226	7.97	14.11	3.95	4203	6.77380378	DR
260	7.274	116.272378517	6.256	14.11	3.95	3523	6.77598721	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AGDXFAntioqua Gold Inc (CE)	US$ 0.02 (1,999,900.00%)	2.5k
ISUNQiSun Inc (CE)	US$ 0.0007 (69,900.00%)	19.21k
TTCFQTattooed Chef Inc (CE)	US$ 0.0002 (19,900.00%)	51.12k
YAYOYayYo Inc (CE)	US$ 0.0001 (9,900.00%)	2.83k
ECPNEl Capitan Precious Metals Inc (CE)	US$ 0.0001 (9,900.00%)	2.25k
EGBBEarth Gen Biofuel Inc (CE)	US$ 0.000001 (-99.95%)	8k
CNVIFConavi Medical Corporation (PK)	US$ 0.0007 (-99.88%)	1.93k
SPRNSupernova Energy Inc (CE)	US$ 0.000001 (-99.67%)	2k
SCNGSC Holdings Corporation (CE)	US$ 0.000001 (-99.50%)	55k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.000001 (-99.50%)	2.4k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0001 (0.00%)	210.2M
HCMCHealthier Choices Management Corporation (PK)	US$ 0.00005 (4,900.00%)	115.06M
THBDThird Bench Inc (PK)	US$ 0.0003 (200.00%)	112.63M
QEDNQED Connect Inc (PK)	US$ 0.0005 (25.00%)	78.09M
RDARRaadr Inc (PK)	US$ 0.0007 (16.67%)	70.75M

manibiotech

manibiotech 43秒前

However the data of current trial submitted for approval is not "in vitro"

payupdeadbeat

payupdeadbeat 44秒前

It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.

Craig305

Craig305 1分前

This is the highest day volume since June 2022.

Serpico2005

Serpico2005 1分前

HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer.

delerious1

delerious1 1分前

Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the

ExtremelyBullishZig

ExtremelyBullishZig 1分前

No...all biotechs are up based on gene editing company success it move the index

richme

Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).

Quintessence

Quintessence 2分前

PDYNW - Nice move today! I will consider buying dips.

JRoon71

JRoon71 2分前

TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to

dennisdave

dennisdave 2分前

BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.

attilathehunt

attilathehunt 2分前

1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0

bgATL

Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it

I wonder if .0011 is a good entry? Fishing time. 🎣

konshe

Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.

al44

The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner

When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.

Real McCoy

Real McCoy 3分前

I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.

KRISGO

Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?

PennyMillions852

PennyMillions852 3分前

BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!

Hitman970

Hitman970 3分前

Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.

CrashOverride

CrashOverride 3分前

If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.

biotechinvestor1

biotechinvestor1 3分前

From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”

BamaBreeze

BamaBreeze 4分前

Can you bring in the update your referencing(please).

redspinelpinktopaz

redspinelpinktopaz 4分前

No. It seems all right to me.

glenn1919

glenn1919 4分前

TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

WinstonCup

WinstonCup 4分前

Sometimes you make no sense.

Konecranes (PK)

Vontobel Financial Produ...

BNP Paribas Issuance

Ci Canadian Dividend Pri...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約